IPO Porto FG, EPE /ID# 154138

Porto 4200-072

0 studies enrolling now · 1 studies all time

What they study most

Acute Myeloid Leukemia (AML)

Studies at this site

• A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy — Running, not enrolling